These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26198649)

  • 1. Response evaluation of the neck in oropharyngeal cancer: Value of magnetic resonance imaging and influence of p16 in selecting patients for post-radiotherapy neck dissection.
    Lilja-Fischer JK; Jensen K; Eskildsen HW; Fink-Jensen V; Nielsen VE
    Acta Oncol; 2015; 54(9):1599-606. PubMed ID: 26198649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival.
    Sandulache VC; Ow TJ; Daram SP; Hamilton J; Skinner H; Bell D; Rosenthal DI; Beadle BM; Ang KK; Kies MS; Johnson FM; El-Naggar AK; Myers JN
    Head Neck; 2013 Oct; 35(10):1454-60. PubMed ID: 23018868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16 status and interval neck dissection findings after a 'clinically complete response' to chemoradiotherapy in oropharyngeal squamous cell carcinoma.
    Miah MS; Spielmann P; White SJ; Kennedy C; Kernohan N; Mountain RE; Cassasola R; Mahendran S
    J Laryngol Otol; 2015 Aug; 129(8):801-6. PubMed ID: 26087671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: the role of US, MRI and FDG-PET/TC scans to assess residual neck disease.
    Pellini R; Manciocco V; Turri-Zanoni M; Vidiri A; Sanguineti G; Marucci L; Sciuto R; Covello R; Sperduti I; Kayal R; Anelli V; Pichi B; Mercante G; Spriano G
    J Craniomaxillofac Surg; 2014 Dec; 42(8):1834-9. PubMed ID: 25150165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult contralateral nodal disease in oropharyngeal squamous cell carcinoma patients undergoing primary TORS with bilateral neck dissection.
    McMullen CP; Garneau J; Weimar E; Ali S; Farinhas JM; Yu E; Som PM; Sarta C; Goldstein DP; Su S; Xu W; Smith RV; Miles B; de Almeida JR
    Oral Oncol; 2019 Jun; 93():96-100. PubMed ID: 31109703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas.
    Shinohara S; Kikuchi M; Tona R; Kanazawa Y; Kishimoto I; Harada H; Imai Y; Usami Y
    Jpn J Clin Oncol; 2014 Mar; 44(3):232-40. PubMed ID: 24470584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No benefit for regional control and survival by planned neck dissection in primary irradiated oropharyngeal cancer irrespective of p16 expression.
    Maquieira R; Haerle SK; Huber GF; Soltermann A; Haile SR; Stoeckli SJ; Broglie MA
    Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1841-8. PubMed ID: 26059208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclo-oxygenase-2 Expression Is Associated With Lymph Node Metastasis in Oropharyngeal Squamous Cell Carcinoma Under the New TNM Classification.
    Sekimizu M; Ozawa H; Saito S; Ikari Y; Nakahara N; Nakamura S; Yoshihama K; Ito F; Watanabe Y; Imanishi Y; Kameyama K; Ogawa K
    Anticancer Res; 2019 Oct; 39(10):5623-5630. PubMed ID: 31570459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting residual neck disease in patients with oropharyngeal squamous cell carcinoma treated with radiation therapy: utility of p16 status.
    Shonka DC; Shoushtari AN; Thomas CY; Moskaluk C; Read PW; Reibel JF; Levine PA; Jameson MJ
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1126-32. PubMed ID: 19917926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the lymph node ratio in oropharyngeal carcinoma stratified for HPV-status.
    Jacobi C; Rauch J; Hagemann J; Lautz T; Reiter M; Baumeister P
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):515-524. PubMed ID: 29204919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer.
    Garden AS; Gunn GB; Hessel A; Beadle BM; Ahmed S; El-Naggar AK; Fuller CD; Byers LA; Phan J; Frank SJ; Morrison WH; Kies MS; Rosenthal DI; Sturgis EM
    Cancer; 2014 Oct; 120(19):3082-8. PubMed ID: 24898672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Papillomavirus-Associated Oropharyngeal Cancer: Patterns of Nodal Disease.
    Plonowska KA; Strohl MP; Wang SJ; Ha PK; George JR; Heaton CM; El-Sayed IH; Mallen-St Clair J; Ryan WR
    Otolaryngol Head Neck Surg; 2019 Mar; 160(3):502-509. PubMed ID: 30274544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of p16 levels and pre-radiotherapy factors predicts outcome in patients treated for oropharyngeal carcinoma.
    Bar-Ad V; Wang ZX; Leiby B; Tuluc M
    J BUON; 2013; 18(4):982-8. PubMed ID: 24344027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Level V lymph node dissection in oral and oropharyngeal carcinoma patients with clinically node-positive neck: is it absolutely necessary?
    Lim YC; Koo BS; Lee JS; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1232-5. PubMed ID: 16826066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of p16 Status on the Development of a Complete Response in Involved Oropharynx Cancer Neck Nodes After Cisplatin-Based Chemoradiation: A Secondary Analysis of NRG Oncology RTOG 0129.
    Galloway TJ; Zhang QE; Nguyen-Tan PF; Rosenthal DI; Soulieres D; Fortin A; Silverman CL; Daly ME; Ridge JA; Hammond JA; Le QT
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):362-371. PubMed ID: 27478170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frequency and distributions of cervical lymph node metastases in oropharyngeal squamous cell carcinoma].
    Akashi K; Hayashi R; Shinozaki T; Miyazaki M; Daiko H; Ebihara M
    Nihon Jibiinkoka Gakkai Kaiho; 2013 Oct; 116(10):1100-5. PubMed ID: 24313060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodal response after 46 Gy of intensity-modulated radiotherapy is associated with human papillomavirus-related oropharyngeal carcinoma.
    Dronkers EAC; Koljenovic S; Verduijn GM; Baatenburg de Jong RJ; Hardillo JAU
    Laryngoscope; 2018 Oct; 128(10):2333-2340. PubMed ID: 29521420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Extracapsular Spread With Survival According to Human Papillomavirus Status in Oropharynx Squamous Cell Carcinoma and Carcinoma of Unknown Primary Site.
    Kharytaniuk N; Molony P; Boyle S; O'Leary G; Werner R; Heffron C; Feeley L; Sheahan P
    JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):683-690. PubMed ID: 27196434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.
    Lim YC; Koo BS; Lee JS; Lim JY; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1148-52. PubMed ID: 16826050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.